SEC Form 4 · accession 0001645627-17-000025
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Mar 29, 2017
Accepted (ET)
Apr 3, 2017 · 2:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.0405 | A | 19,945,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.042 | A | 19,947,249 | D | |
| Common Stock | Mar 29, 2017 | P | 1,000 | $0.039 | A | 19,948,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.0417 | A | 19,950,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.04 | A | 19,952,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.04 | A | 19,954,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.04 | A | 19,956,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.042 | A | 19,958,249 | D | |
| Common Stock | Mar 29, 2017 | P | 2,000 | $0.042 | A | 19,960,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.042 | A | 19,962,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.0419 | A | 19,964,249 | D | |
| Common Stock | Mar 30, 2017 | P | 1,000 | $0.042 | A | 19,965,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.041 | A | 19,967,249 | D | |
| Common Stock | Mar 30, 2017 | P | 1,000 | $0.041 | A | 19,968,249 | D | |
| Common Stock | Mar 30, 2017 | P | 1,000 | $0.041 | A | 19,969,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.0421 | A | 19,971,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.045 | A | 19,973,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.047 | A | 19,975,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.05 | A | 19,977,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.05 | A | 19,979,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.05 | A | 19,981,249 | D | |
| Common Stock | Mar 30, 2017 | P | 1,000 | $0.045 | A | 19,982,249 | D | |
| Common Stock | Mar 30, 2017 | P | 1,000 | $0.0485 | A | 19,983,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.05 | A | 19,985,249 | D | |
| Common Stock | Mar 30, 2017 | P | 1,000 | $0.05 | A | 19,986,249 | D | |
| Common Stock | Mar 30, 2017 | P | 2,000 | $0.048 | A | 19,988,249 | D | |
| Common Stock | Mar 30, 2017 | P | 100 | $0.0474 | A | 19,988,349 | D | |
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.055 | A | 19,900,349 | D | |
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.055 | A | 19,992,349 | D | |
| Common Stock | Mar 31, 2017 | P | 2,000 | $0.0536 | A | 19,994,349 | D |
Table II — derivative securities
No Table II lines on this filing.